Procurement of one (1) each PAK system continuous manufacturing instrument
Ended Purchase Order Awarded Last action
- Contract number
- 75F40124P00300
- Awardee
-
PAK Biosolutions, Inc. UEI D2BBLN4AKAW5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $451,200
Award facts
- Contract value 79% obligated
-
- $451,200.00 Current, with exercised options
- $573,760.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $451,200 |
About this award
This is a $573,760 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The contract is for the procurement of one PAK System continuous manufacturing instrument, which is a specialized scientific instrument used in pharmaceutical process development and manufacturing. This contract has been designated as a Total Small Business set-aside. In addition to this contract, PAK Biosolutions has also received a $504,522 contract from the FDA for an Integrated Continuous Purification System, as well as smaller contract awards for parts and components. The company has further received grant funding from the National Center for Advancing Translational Sciences, a branch of the National Institutes of Health, to develop a laboratory-scale version of their continuous manufacturing system, which aims to enable more efficient process development and potentially reduce biopharmaceutical manufacturing costs.
Quick answers
Who was awarded contract 75F40124P00300?
75F40124P00300 was awarded to PAK Biosolutions, Inc. by Food and Drug Administration (Department of Health and Human Services) on July 12, 2024.
How much is contract 75F40124P00300 worth?
The government has obligated $451,200 on 75F40124P00300. Its potential value, with all options, is $573,760.
Was contract 75F40124P00300 competed?
The extent of competition for 75F40124P00300 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award